Our Mission‎ > ‎

Our Competitive Advantage

MediLogos software company has developed an innovative medical care platform whose clinical decision support and clinical data analysis systems provide real-time, seamless integration of patient data and clinical knowledge, designed to resolve physicians' cognitive overload and enable analysis of single and multiple patient data in limited time. 

By combining two systems, one that summarizes medical data as clinically meaningful concepts which saves up to 90% of clinician decision-making time*, and one that recommends appropriate medical treatment, we reduce errors*.  MediLogos' platform provides clinical data analysis and visualization, evidence-based recommendations, and long-term knowledge-based monitoring capabilities, which improve clinical decision-making, enhancing the quality of care and reducing costs.

 (*per clinical trials)

MediLogos' Competitive Advantages:

1. Longitudinal care clinical decision support systems.

  • Can reduce the costs and improve the quality of care for chronic care patient treatment and management.
2. Automated guideline application at the point of care.
  • At the clinic, in the ward, as a telemedicine or telehealth service, or the patient’s home.
  • An automated trace of every decision and action.
3. Comprehensive knowledge engineering methodology.
  • Caters to a guideline’s full life cycle.
  • Provides fast updates of clinical best practices.
4. An intelligent mediator to the patient data.
  • Enables mapping to multiple clinical-database formats and querying these databases for either raw data or more abstract clinical concepts and time-oriented patterns.
5. Visualization and exploration of individual and multiple longitudinal patient records.
  • The multiple-patient module enables us to solve the problem of monitoring multiple subjects over time, as well as for extracting and exploring statistically meaningful temporal associations and patterns emerging from the population-based data
6. Aggregation and dissemination of clinical knowledge to support evidence-based medicine.


Value Proposition:

  1. To ISVs – provides a clinical decision support system that will ensure adherence to clinical guidelines. This will dramatically enhance their systems.
  2. To CDOs – will reduce costs of chronic-care patient management.
  3. Pharmaceutical companies - will increase compliance with clinical trial protocols, improve interpretation of trial results, improve collaboration between clinicians and statisticians, and improve efficiency of trials.
Subpages (1): Unique System Features